17 | Humans |
12 | Male |
11 | Football (injuries) |
5 | Adult |
4 | Risk Factors |
4 | Human |
4 | Football |
4 | Football (statistics & numerical data) |
4 | Football (physiology) |
4 | Athletic Injuries (etiology) |
3 | Prospective Studies |
3 | Magnetic Resonance Imaging |
3 | Incidence |
3 | Female |
3 | Biomechanical Phenomena (physiology) |
3 | Athletic Injuries (epidemiology) |
3 | Adolescent |
2 | user experience design |
2 | mouth, diseases |
2 | immunohistochemistry |
2 | gingivitis |
2 | agile software development |
2 | agile development |
2 | Time and Motion Studies |
2 | Time Factors |
2 | Spinal Injuries (physiopathology) |
2 | Spinal Injuries (etiology) |
2 | Spinal Cord Injuries (prevention & control) |
2 | Spinal Cord Injuries (pathology) |
2 | Spinal Cord Injuries (etiology) |
2 | Spinal Cord Injuries (epidemiology) |
2 | Spinal Cord (pathology) |
2 | Posture (physiology) |
2 | Porphyromonas gingivalis |
2 | Physical Fitness |
2 | Neck Injuries (etiology) |
2 | Neck Injuries (epidemiology) |
2 | Great Britain (epidemiology) |
2 | England (epidemiology) |
2 | Cross-Sectional Studies |
2 | Competitive Behavior |
2 | Cervical Vertebrae (injuries) |
2 | Biomechanical Phenomena |
2 | Athletic Performance |
2 | Athletic Injuries (physiopathology) |
2 | Athletic Injuries (complications) |
2 | Antigen |
2 | Antibody |
1 | “high molecular weight” RNA |
1 | “heavy” dRNA |
1 | “control” embryos |
1 | ω-conotoxin |
1 | ω-CgTx |
1 | wort boiling method |
1 | waste |
1 | volatile compound |
1 | vitamin E |
1 | vitamin B |
1 | vehicles. |
1 | urban areas |
1 | ulcerations, recurrent aphthous |
1 | tumour marker |
1 | trypsin inhibitory units |
1 | trichloroacetic acid |
1 | training |
1 | thickness |
1 | tetra-ethylammonium acetate |
1 | testosterone |
1 | testis |
1 | supraoptic nucleus |
1 | sulphur organic compound |
1 | succession |
1 | structural |
1 | squamous cell carcinoma |
1 | sports equipment |
1 | spinal injury |
1 | spin doctor |
1 | software risk assessment |
1 | software process assessment |
1 | small software companies |
1 | situated action |
1 | serum |
1 | serum immunoglobulins |
1 | serospecificity |
1 | serodiagnosis |
1 | scrum |
1 | scaling and root planing |
1 | saliva |
1 | safety critical software |
1 | rubella |
1 | routine diagnosis |
1 | rotavirus |
1 | rotavirus class‐specific antibodies |
1 | reference methods |
1 | recurrent aphthous stomatitis |
1 | receptor |
1 | radioimmunoassay |
1 | rRNA |
1 | quadriplegia |
1 | pyridinium crosslinks |
1 | psychosocial deprivation |
1 | protein binding |
1 | projects |
1 | prognosis |
1 | pregnancy |
1 | predictive value |
1 | positron emission tomography |
1 | positional information |
1 | polyvalent vaccine |
1 | polyphenol |
1 | pneumoconiosis |
1 | platelets |
1 | plasma lipoproteins |
1 | plasma cells |
1 | plaque |
1 | pituicyte |
1 | pigeons |
1 | pigeon keepers |
1 | photocontact allergy |
1 | photoconjugate |
1 | photoallergen |
1 | peripheral benzodiazepine binding sites |
1 | periodontitis |
1 | periodic structures |
1 | performances |
1 | pemphigis vulgaris |
1 | pastes |
1 | oxytocin |
1 | osteocalcin |
1 | orthodontic tooth movement |
1 | oral lesions |
1 | opsonization |
1 | opioid receptor |
1 | open‐source software |
1 | oestrogen receptors |
1 | nucleic acid homology |
1 | non‐A, non‐B hepatitis |
1 | nitrogenous compounds |
1 | nicotinamide adenine dinucleotide |
1 | neurohypophysis |
1 | myelomonocytic antigens |
1 | mycoses |
1 | mycobacteria |
1 | mouth‐disease |
1 | monocytes |
1 | monoclonal gammopathy |
1 | mining exposure |
1 | microtubules |
1 | microbiology |
1 | metronidazole |
1 | metaphor |
1 | megakaryocytes |
1 | mechanism |
1 | mean platelet volume |
1 | managerial complexity |
1 | malt constituent |
1 | maintenance therapy |
1 | lymphoma |
1 | lithium weight loss |
1 | lipid peroxidation |
1 | lean software development |
1 | large‐scale development |
1 | kinetics |
1 | keratoconjunctivitis |
1 | isotypes |
1 | isobutylmethylxanthine |
1 | international standards |
1 | insulin‐dependent diabetes mellitus |
1 | infant |
1 | industrial ecosystem |
1 | immunology |
1 | immunoglobulin |
1 | immunofluorescent antibody test |
1 | immunocytochemistry |
1 | immune electron microscopy |
1 | immune competence |
1 | humans |
1 | human periodontal disease |
1 | human adenovirus |
1 | herpetic gingivostomatitis |
1 | hepatic encephalopathy |
1 | hepatic copper/caerulo‐plasmin |
1 | hemoconcentration |
1 | heat |
1 | heat stress |
1 | haze |
1 | hCGβ |
1 | growth |
1 | growth factor |
1 | glueocorticoid resistance |
1 | global software development |
1 | glibenclamide therapy |
1 | glial cell lines |
1 | glia |
1 | gingival fluid |
1 | geriatrics, oral health: trace elements, vitamins |
1 | gastroenteritis |
1 | gamma aminobutyric acid |
1 | galactocerebroside |
1 | folate |
1 | foam |
1 | feathers |
1 | feather miles |
1 | failure to thrive |
1 | ethylenediamine tetra-acetate |
1 | ethyl-eneglycolbis(aminoethylether)tetra-acetate |
1 | ethopropazine, 10-(2-diethylaminopropyl)-phenothiazine hydrochloride |
1 | erythema multiforme |
1 | epithelial neoplasia |
1 | enzyme‐linked immunosorbent assay |
1 | energy balance |
1 | empirical studies |
1 | electrolyte inbalance |
1 | eczema herpeticum |
1 | ecological principles |
1 | dynamic |
1 | drug induced |
1 | doubling time |
1 | diversity |
1 | dithiothreitol |
1 | distributed teamwork |
1 | disorder |
1 | dimethylsulphide |
1 | dihydropyridine |
1 | differentiation |
1 | diarrhaea |
1 | dRNA |
1 | c‐erbB‐2 |
1 | cytoskeleton |
1 | cytomegalovirus IgM antibodies |
1 | cytokines |
1 | crevicular fluid‐darkfield microscopy |
1 | corruption |
1 | cooperative work |
1 | contextualization |
1 | context awareness |
1 | cognition |
1 | coalworkers |
1 | clientelism |
1 | class |
1 | chewing sticks |
1 | chemiluminescence |
1 | cervical neurapraxia |
1 | caste |
1 | case study |
1 | carcinoma |
1 | carbohydrate antigen |
1 | calcium hydroxide |
1 | breast milk |
1 | bovine serum albumin |
1 | bone biochemistry |
1 | blastomycosis |
1 | bladder cancer |
1 | beer |
1 | beer quality |
1 | avidity |
1 | asthma |
1 | aspermatogenesis |
1 | articulation work |
1 | apparent half‐life |
1 | apoptosis |
1 | aphthae |
1 | antigens |
1 | antibody |
1 | antibody response |
1 | allergy |
1 | agriculture |
1 | affective |
1 | adult periodontitis |
1 | adhesion molecules |
1 | adenovirus |
1 | adenovirus 41 |
1 | adenovirus 40 |
1 | adenocarcinoma |
1 | acclimatization |
1 | Young Adult |
1 | Work team |
1 | Wilson's disease |
1 | WHO |
1 | Viral Vaccines (administration & dosage) |
1 | Video Recording |
1 | Vertebrobasilar Insufficiency (pathology) |
1 | Vertebrobasilar Insufficiency (etiology) |
1 | Vertebral canal |
1 | Vertebral Artery (pathology) |
1 | Vertebral Artery (injuries) |
1 | Validation |
1 | Vaccines, Inactivated (administration & dosage) |
1 | Vaccine |
1 | Vaccination |
1 | V |
1 | V. parvula |
1 | Uttar Pradesh |
1 | Urticarial |
1 | Urticaria |
1 | Urban atmosphere |
1 | Unified model |
1 | UMP/CMP and AMP/GMP |
1 | U/C |
1 | Tris-buffered saline |
1 | Triamcinolone |
1 | Treatment |
1 | Transportation of Patients |
1 | Torso (injuries) |
1 | Torg ratio |
1 | Tomography, X-Ray Computed |
1 | TmPAH |
1 | Thorax |
1 | Thermal energy storage |
1 | Testis |
1 | Team work |
1 | Targeting |
1 | TPBS |
1 | TIU |
1 | TEA-Ac |
1 | TCA |
1 | TBS |
1 | Synovial membrane |
1 | Symmetrical pustular eruption |
1 | Surface energy |
1 | Stress, Physiological |
1 | Stress, Physiological (physiology) |
1 | Streptococcus sanguis |
1 | Standardization |
1 | Stability |
1 | Sports medicine |
1 | Spine |
1 | Spinal Injuries (radiography) |
1 | Spinal Injuries (pathology) |
1 | Spinal Cord Injuries (therapy) |
1 | Spinal Cord Injuries (radiography) |
1 | Spinal Cord Injuries (history) |
1 | Spinal Cord (radiography) |
1 | Spinal Cord (abnormalities) |
1 | Spermatozoa |
1 | South Africa (epidemiology) |
1 | Simplexvirus (immunology) |
1 | Shoes |
1 | Sexual Partners |
1 | Serum |
1 | Seroma (prevention & control) |
1 | Sensation |
1 | SIL‐2R |
1 | S-type dendrite |
1 | Running |
1 | Rugby |
1 | Risk Assessment |
1 | Rhinitis |
1 | Rheumatoid arthritis |
1 | Review |
1 | Retrospective Studies |
1 | Rats |
1 | Rats, Inbred Strains |
1 | Rat |
1 | Radiation |
1 | RSB |
1 | RAD |
1 | Pyridinoline |
1 | Pubertal |
1 | Property formulation relationship |
1 | Professional Competence (standards) |
1 | Prevotella intermedia |
1 | Pressure |
1 | Postoperative Complications (prevention & control) |
1 | Polymorphonuclear neutrophils |
1 | Polymerase chain reaction |
1 | Planning |
1 | Physical urticaria |
1 | Physical Endurance (physiology) |
1 | Pharmacokinetics |
1 | Phagcyte |
1 | Personal Protective Equipment |
1 | Periodontal treatment |
1 | Pattern formation |
1 | Pathogenesis |
1 | Parvovirus B19 |
1 | Parotid Diseases (surgery) |
1 | Parathyroid hormone |
1 | Paracoccidioidomycosis |
1 | Paget's disease of the nipple |
1 | PK11195 |
1 | PET, positron emission tomography |
1 | PDGF |
1 | PBBS, peripheral benzodiazepine binding sites |
1 | PAH |
1 | P-type dendrite |
1 | O‐2A progenitor |
1 | Ovalbumin |
1 | Otorhinolaryngologic Surgical Procedures (adverse effects) |
1 | Osteocalcin |
1 | Osteoarthritis |
1 | Osmolar Concentration |
1 | Obesity |
1 | Nordazepam (pharmacology) |
1 | Nordazepam (blood) |
1 | Nordazepam (administration & dosage) |
1 | Nonidet P-40 |
1 | New Zealand (epidemiology) |
1 | Neck Injuries (therapy) |
1 | NP-40 |
1 | NMDG |
1 | NCT, number connection tests |
1 | NAD |
1 | N-methyl-d-glucamine |
1 | N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid |
1 | M‐CSF |
1 | Musculoskeletal System (injuries) |
1 | Muscle Weakness (etiology) |
1 | Movement |
1 | Movement (physiology) |
1 | Mouse |
1 | Motor Activity (drug effects) |
1 | Mometasone |
1 | Mexico |
1 | Medullary tetraplegia |
1 | Medical Audit |
1 | Mechanism |
1 | Materials Testing |
1 | MRS, magnetic resonance spectroscopy |
1 | MRI, magnetic resonance imaging |
1 | MODeST |
1 | MCh, acetyl-β-methylcholine |
1 | Lower Extremity |
1 | Lipopolysaccharide |
1 | Leydig |
1 | Leydig cells |
1 | Leu M1 |
1 | Legislation, Medical |
1 | Legal medicine |
1 | Lactic acid copolymer |
1 | Lactates (blood) |
1 | Klebsiella |
1 | Ireland (epidemiology) |
1 | Intranasal administration |
1 | Injury Severity Score |
1 | Infection |
1 | India |
1 | Immunogenicity |
1 | Immunization |
1 | Immune response |
1 | IgM |
1 | IgG |
1 | IgG antibody |
1 | IgE. RAST. AlaSTAT EIA. Diplaegidia columbae |
1 | ISDM |
1 | IL‐4 |
1 | IL‐2 |
1 | IBMX |
1 | Hypnotics and Sedatives (pharmacology) |
1 | Hypnotics and Sedatives (blood) |
1 | Hypnotics and Sedatives (administration & dosage) |
1 | Humoral immunity |
1 | Hospitalization (statistics & numerical data) |
1 | History, 20th Century |
1 | Herpes Simplex (transmission) |
1 | Herpes Simplex (prevention & control) |
1 | Herpes Simplex (epidemiology) |
1 | Hereditary angio‐oedema |
1 | HSV infection |
1 | HRP |
1 | HEPES |
1 | HE, hepatic encephalopathy |
1 | HCV, hepatitis C virus |
1 | Glycolic acid copolymer |
1 | Glucocorticoid |
1 | Geographic Information Systems |
1 | GAD |
1 | GABAA receptors |
1 | GABA |
1 | GABA, gamma-aminobutyric acid |
1 | Fusobacterium nucleatum |
1 | Fura‐2 |
1 | Forensic aspect |
1 | Football (history) |
1 | Follow-Up Studies |
1 | Fitness |
1 | Femoral neck fracture |
1 | Fatal Outcome |
1 | Extremities (injuries) |
1 | Exercise |
1 | Evolution |
1 | Ethylene oxide polymer |
1 | Escherichia coli |
1 | Equipment Design |
1 | England |
1 | Encapsulation |
1 | Embolism (surgery) |
1 | Embolism (pathology) |
1 | Embolism (etiology) |
1 | EGTA |
1 | EEG, electroencephalogram |
1 | EDTA |
1 | EDL |
1 | ECM proteins |
1 | Drug Tolerance |
1 | Dislocations (therapy) |
1 | Dislocations (pathology) |
1 | Dislocations (etiology) |
1 | Dislocations (epidemiology) |
1 | Dislocations (complications) |